slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
51,2 TWD | -0,19% | +1,39% | -12,18% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Health Products (including Food)
68,7
%
| - | - | 433 | 68,7 % | - |
Pharmaceuticals
29,8
%
| - | - | 188 | 29,8 % | - |
Others (Note)
0,9
%
| 15 | 2,2 % | 5 | 0,9 % | -64,02% |
Cleaning Products
0,6
%
| - | - | 4 | 0,6 % | - |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
100,0
%
| 684 | 100,0 % | 629 | 100,0 % | -8,02% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yu Hsiu Cheng
CEO | Chief Executive Officer | - | - |
Li Yu Lin
DFI | Director of Finance/CFO | - | 20-10-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yu Hsiu Cheng
CEO | Chief Executive Officer | - | - |
Pa Chou Hsieh
BRD | Director/Board Member | - | 25-08-14 |
Yong Sheng Wang
BRD | Director/Board Member | - | 25-08-14 |
Ya I Huang
BRD | Director/Board Member | - | 08-06-17 |
Hui Chien Li
BRD | Director/Board Member | - | 01-12-17 |
Hung Yuan Lin
BRD | Director/Board Member | - | 08-06-17 |
Jui Hsiang Hsu
BRD | Director/Board Member | - | 08-06-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 31 807 000 | 10 752 500 ( 33,81 %) | 0 | 33,81 % |
Bedrijfsgegevens
Li Kang Biomedical Co. Ltd.
9F, 21, Lane 221, Gangqian Road Neihu District
114, Taipei
+
http://www.bafo.com.twSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,18% | 50,07 mln. | |
+11,85% | 8,05 mld. | |
+5,29% | 7,59 mld. | |
+2,63% | 6,07 mld. | |
-2,80% | 3,85 mld. | |
-11,22% | 3,55 mld. | |
-7,04% | 1,28 mld. | |
-32,50% | 1,03 mld. | |
+12,52% | 971 mln. | |
-15,69% | 813 mln. |
- Beurs
- Aandelen
- Koers 6242
- Onderneming Li Kang Biomedical Co., Ltd.